Oct, 1, 2023

Vol.30 No.2, pp. 84-88

Current Issue Archives
Search
Advanced Search
Editorial Office

Review

  • Korean Journal of Biological Psychiatry
  • Volume 21(3); 2014
  • Article

Review

Korean Journal of Biological Psychiatry 2014;21(3):99-106. Published online: Mar, 1, 2014

Abstract PDF Full Text

Association Analysis between (AAT)n Repeats in the Cannabinoid Receptor 1 Gene and Schizophrenia in a Korean Population

  • Ji-Won Kim, MD1;Yang-Ho Roh, MD1;Min-Jea Kim, MD1;Chea-Ri Kim, MD1;Byung-Lae Park, PhD2;Joon Seol Bae, PhD3;Hyoung Doo Shin, PhD4;Ihn-Geun Choi, MD5;Sang-Woo Han, MD1;Jaeuk Hwang, MD1; and Sung-Il Woo, MD1;
    1;Department of Psychiatry, Soonchunhyang University Seoul Hospital, College of Medicine, Soonchunhyang University, Seoul, 2;Department of Genetic Epidemiology, SNP Genetics, Inc., Seoul, 3;Laboratory of Translational Genomics, Samsung Genome Institute, Samsung Medical Center, Seoul, 4;Department of Life Science, Sogang University, Seoul, 5;Department of Neuropsychiatry, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea
Abstract

Objectives : Previous studies suggest that the cannabinoid receptor 1 (CNR1) gene could be an important candidate gene for schizophrenia. According to linkage studies, this gene is located on chromosome 6q14-q15, which is known to harbor the schizophrenia susceptibility locus (locus 5, SCZ5, OMIM 803175). The pharmacological agent delta-9-tetrahydrocannabinol (Δ-9-THC) seems to elicit the symptoms of schizophrenia. The association between CNR1 polymorphisms and schizophrenia is actively being investigated, and some studies have linked the AAT-trinucleotide repeats in CNR1 to the onset of schizophrenia. In this study, we have investigated the association between the AAT-trinucleotide repeats in CNR1 and schizophrenia by studying schizophrenia patients and healthy individuals from Korea.

Methods : DNA was extracted from the blood samples of 394 control subjects and 337 patients diagnosed with schizophrenia (as per the Diagnostic and Statistical Manual of Mental Disorders, fourth edition criteria). After polymerase chain reaction amplification, a logistic regression analysis, with age and gender as the covariates, was performed to study the variations in the AAT-repeat polymorphisms between the two groups.

Results : In total, 8 types of trinucleotide repeats were identified, each containing 7, 8, 10, 11, 12, 13, 14, and 15 repeats, respectively. (AAT)13 allele was most frequently observed, with a frequency of 33.6% and 31.6% in the patient and control groups, respectively. The frequency of the other repeat alleles in the patient group (in the decreasing order) was as follows : (AAT)13 33.6%, (AAT)14 21.6%, (AAT)12 18.5%, and (AAT)7 11.1%. The frequency of the repeat alleles in the control group (in the decreasing order) was as follows : (AAT)13 31.6%, (AAT)14 24.5%, (AAT)12 17.2%, and (AAT)7 11.6%. However, there were no significant differences in the AAT-repeat polymorphisms of the CNR1 gene between the patient group and the control group.

Conclusions : Although our study revealed no significant association of the AAT-repeat polymorphism of the CNR1 gene with schizophrenia, it will serve as a good reference for future studies designed to examine the cannabinoid hypothesis of schizophrenia.

Keywords Schizophrenia;Cannabinoid receptor 1 gene;AAT repeats polymorphism.